BRPI0407991A - "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos". - Google Patents

"composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".

Info

Publication number
BRPI0407991A
BRPI0407991A BRPI0407991-4A BRPI0407991A BRPI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A BR PI0407991 A BRPI0407991 A BR PI0407991A
Authority
BR
Brazil
Prior art keywords
treating
subject
composition
infection
fungal
Prior art date
Application number
BRPI0407991-4A
Other languages
English (en)
Inventor
Richard B Klein
Jeffrey L Selph
John J Partridge
John F Reinhard
Original Assignee
Mycosol Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mycosol Inc filed Critical Mycosol Inc
Publication of BRPI0407991A publication Critical patent/BRPI0407991A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)

Abstract

"COMPOSTO, MéTODO PARA TRATAR UM PRODUTO INDUSTRIAL COM CRESCIMENTO FúNGICO, COMPOSIçãO, PROCESSO SINTéTICO PARA PREPARAR A COMPOSIçãO, E, MéTODOS PARA CONTROLAR FUNGOS E/OU BACTéRIAS, PARA TRATAR UMA INFLAMAçãO EM UM SUJEITO, PARA TRATAR UMA INFECçãO EM UM SUJEITO, PARA TRATAR UM DISTúRBIO AUTO-IMUNE EM UM SUJEITO E PARA PROTEGER UMA PLANTA DE INFECçãO FúNGICA, MICROCáPSULA, E, MéTODO PARA CONTROLAR INSETOS". Divulga-se compostos de sais de piridínio e métodos de sua utilização na medicina, particularmente na profilaxia e no tratamento de condições inflamatórias, condições infecciosas, e também distúrbios imunológicos. A presente invenção refere-se também a métodos de controlar fungos e/ou bactérias. Adicionalmente, a presente invenção refere-se a infestações fúngicas ou bacterianas relativas a usos industriais e agrícolas. A presente invenção também pode ser usada para controlar insetos.
BRPI0407991-4A 2003-03-03 2004-03-03 "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos". BRPI0407991A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US45059903P 2003-03-03 2003-03-03
US48099503P 2003-06-23 2003-06-23
US52477503P 2003-11-25 2003-11-25
US52507503P 2003-11-25 2003-11-25
US52478403P 2003-11-25 2003-11-25
PCT/US2004/006437 WO2004078136A2 (en) 2003-03-03 2004-03-03 Pyridinium salts, compounds and methods of use

Publications (1)

Publication Number Publication Date
BRPI0407991A true BRPI0407991A (pt) 2006-03-07

Family

ID=32966824

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0407991-4A BRPI0407991A (pt) 2003-03-03 2004-03-03 "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".

Country Status (11)

Country Link
US (5) US7220761B2 (pt)
EP (1) EP1601652B1 (pt)
JP (1) JP4742028B2 (pt)
KR (1) KR20050108373A (pt)
AT (1) ATE402924T1 (pt)
AU (1) AU2004218452A1 (pt)
BR (1) BRPI0407991A (pt)
CA (1) CA2517461A1 (pt)
DE (1) DE602004015425D1 (pt)
MX (1) MXPA05009449A (pt)
WO (1) WO2004078136A2 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1601652B1 (en) * 2003-03-03 2008-07-30 Mycosol, Inc. Pyridinium salts, compounds and methods of use
SE527166C2 (sv) * 2003-08-21 2006-01-10 Kerttu Eriksson Förfarande och anordning för avfuktning
MX2007007337A (es) * 2004-12-17 2007-08-22 Mycosol Inc Compuestos tiazolio y sus usos.
JP4750804B2 (ja) * 2005-02-24 2011-08-17 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト カプセル製剤
KR20080003402A (ko) * 2005-04-08 2008-01-07 마이코솔 인코포레이티드 스틸바쥼 연구 분석법
US20080295582A1 (en) * 2005-06-21 2008-12-04 Peng Lee Nondestructive Residential Inspection Method
WO2007056340A2 (en) * 2005-11-08 2007-05-18 Mycosol, Inc. Disinfectant and antiseptic pyridinium and thiazolium compounds and methods of using the same
WO2007056556A2 (en) * 2005-11-08 2007-05-18 Mycosol, Inc. Polyethylene glycol conjugates of pyridinium and thiazolium compounds and methods of using the same
US20070227399A1 (en) * 2006-04-03 2007-10-04 Novus International Inc. Compositions and methods for the preservation of wood
JP2007277790A (ja) * 2006-04-07 2007-10-25 Jae Woo Yang 熱色性物質層を備えたウォールペーパー及びその製造方法
WO2008088917A2 (en) * 2007-01-19 2008-07-24 Mycosol, Inc. Methods of using pyridinium and thiazolium compounds as reagents, diagnostic compounds and therapeutic agents
EP2265105A1 (en) * 2008-03-10 2010-12-29 Basf Se Encapsulated phase change materials in seed coatings
US9538762B2 (en) * 2009-12-31 2017-01-10 Building Materials Investment Corporation Antimicrobial delivery system for roof coverings
US9642829B2 (en) * 2012-12-04 2017-05-09 The University Of Hong Kong Antifungal compound and uses thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2790E (fr) * 1903-09-22 1904-06-15 David Perret Dispositif moteur électrique à double coupe-circuit
BE616609A (fr) * 1961-04-24 1962-10-18 Wellcome Found Composés ammonium quaternaires, procédé pour les préparer et compositions pharmaceutiques les contenant
NL277327A (pt) * 1961-04-24
US3085935A (en) 1961-04-24 1963-04-16 Burroughs Wellcome Co Method for the elimination of nematode infestations
GB1018454A (en) * 1962-10-18 1966-01-26 Smith Kline French Lab Improvements in or relating to antibacterial and antifungal compositions
ES297752A1 (es) * 1963-03-22 1964-08-16 Wellcome Found Un metodo para la preparaciën de una nueva sal de un catiën de diestilbazol cuaternario
DE1200302B (de) * 1963-04-30 1965-09-09 Bayer Ag Verfahren zur Herstellung von Monosalzen bisquartaerer Pyridiniumverbindungen
US3883658A (en) * 1968-09-19 1975-05-13 Burroughs Wellcome Co Method of treating nematode infestations
US3867535A (en) * 1971-12-01 1975-02-18 Ciba Geigy Corp Thiadiazolium salts as antihelmintic agents
US3934017A (en) * 1971-12-07 1976-01-20 Ciba-Geigy Corporation Anthelmintic composition and method utilizing isothiocyanobenzazoles active ingredients
AR207744A1 (es) 1972-08-10 1976-10-29 Ciba Geigy Ag Procedimiento para la preparacion de nuevos derivados de isotiocianopiridinas
CA1022554A (en) * 1973-03-07 1977-12-13 Haukur Kristinsson 1-carbamoyl-2-alkoxycarbonylaminoimidazo (4,5-b) pyridines
DK645374A (pt) 1974-01-22 1975-09-29 Ciba Geigy Ag
US4105793A (en) * 1976-07-28 1978-08-08 Celanese Corporation Multifunctional acrylates as foliar fungicides
IT7819093A0 (it) * 1977-01-10 1978-01-06 Ciba Geigy Prodotti antielmintici e loro impiego.
NL7800192A (nl) * 1977-01-10 1978-07-12 Ciba Geigy Als anthelmintica geschikte anilinomethyeenmalononi- trilederivaten.
CH634307A5 (de) 1977-04-12 1983-01-31 Ciba Geigy Ag Anthelmintisch wirkende benzimidazolderivate, verfahren zu ihrer herstellung und mittel enthaltend diese wirkstoffe.
CH634306A5 (de) 1977-04-12 1983-01-31 Ciba Geigy Ag Benzimidazolderivate, verfahren zu ihrer herstellung und anthelmintische mittel enthaltend diese verbindungen als wirkstoffe.
GB8323949D0 (en) * 1983-09-07 1983-10-12 Wyeth John & Brother Ltd Pyridinium compounds
JP2941041B2 (ja) * 1990-11-16 1999-08-25 シスメックス株式会社 フローサイトメトリーによる白血球の分類方法
JP3070968B2 (ja) * 1991-05-14 2000-07-31 シスメックス株式会社 尿中の細胞分析用試薬及び方法
CN1148850A (zh) 1995-03-20 1997-04-30 奥里翁电气株式会社 偶氮茋鎓盐及其制备方法和用途
US20030138374A1 (en) * 2000-03-22 2003-07-24 Yukitsuda Kudo Image diagnosis probe based on substituted azobenzene or analogue thereof for disease attributable to amyloid accumulation and composition for image diagnosis containing the same
US20020044962A1 (en) * 2000-06-06 2002-04-18 Cherukuri S. Rao Encapsulation products for controlled or extended release
CA2439542A1 (en) * 2001-02-01 2002-08-08 Joshua S. Salafsky Designs of labels for detection with a surface-selective nonlinear optical technique
CN1394854A (zh) * 2002-07-04 2003-02-05 华东师范大学 多取代吡啶盐类化合物及其制备方法
EP1601652B1 (en) * 2003-03-03 2008-07-30 Mycosol, Inc. Pyridinium salts, compounds and methods of use

Also Published As

Publication number Publication date
US7547444B1 (en) 2009-06-16
US7820696B2 (en) 2010-10-26
US7220761B2 (en) 2007-05-22
US8124626B2 (en) 2012-02-28
KR20050108373A (ko) 2005-11-16
ATE402924T1 (de) 2008-08-15
CA2517461A1 (en) 2004-09-16
US20070213299A1 (en) 2007-09-13
DE602004015425D1 (de) 2008-09-11
MXPA05009449A (es) 2006-04-07
WO2004078136A2 (en) 2004-09-16
EP1601652A2 (en) 2005-12-07
US20090137639A1 (en) 2009-05-28
JP2007525441A (ja) 2007-09-06
US20100267716A1 (en) 2010-10-21
WO2004078136A3 (en) 2004-12-16
US20040235898A1 (en) 2004-11-25
AU2004218452A1 (en) 2004-09-16
JP4742028B2 (ja) 2011-08-10
EP1601652B1 (en) 2008-07-30
US20040224984A1 (en) 2004-11-11

Similar Documents

Publication Publication Date Title
BRPI0407991A (pt) "composto, método para tratar um produto industrial com crescimento fúngico, composição, processo sintético para preparar a composição, e, métodos para controlar fungos e/ou bactérias, para tratar uma inflamação em um sujeito, para tratar uma infecção em um sujeito, para tratar um distúrbio auto-imune em um sujeito e para proteger uma planta de infecção fúngica, microcápsula,e, método para controlar insetos".
BR0107241A (pt) Compostos, processo de preparação dos compostos, uso dos compostos, composições fungicidas, processo de combate preventivo ou curativo dos fungos fitopatogênicos das culturas e método de tratamento preventivo ou curativo da madeira de construção
MX348445B (es) Composicion para el control de enfermedades en plantas y metodo para controlar enfermedades en plantas mediante la aplicación de la composicion.
WO2003037259A3 (en) Methods for the prevention or treatment of bacterial and fungal infections
ATE473630T1 (de) Verfahren zur bekämpfung von pflanzenkrankheitsschäden durch verwendung eines bacillus
DE60012026D1 (de) Verwendung von emu-öl als träger für fungizide, antibakterielle und antivirale arzneien
EA201101426A1 (ru) Способ подавления вредных грибов
BR9713812A (pt) Controle biológico de infecções fúngicas de planta
BRPI0411501A (pt) composto, processos de preparação de composto, composição fungicida e método de combate preventivo ou curativo dos fungos fitopatogênicos
AP2001002275A0 (en) A strain of bacillus pumilus for controlling plant diseases.
WO2005091891A8 (en) Compositions and methods for preventing and treating skin and hair conditions
EP2689783A3 (en) Growth control of oral and superficial microorganisms using gallium compounds
BRPI0416720B8 (pt) composto, processo para a preparação de um composto, composição fungicida e método de combate curativo ou preventivo dos fungos fitopatogênicos de culturas
ATE347401T1 (de) Kosmetische verwendung einer zusammensetzung mit mindestens einem oxazolin als wirkstoff, als abnehmprodukt und/oder zur prävention und/oder behandlung von cellulite
MX2021014421A (es) Composicion fungicida para el control de la infeccion por zymoseptoria en plantas.
MX2022002414A (es) Composiciones y métodos de control patogénico.
BRPI0417421A (pt) composto, composição farmacêutica, método para tratamento ou controle de infecções bacterianas, processo para preparação do composto e produto manufaturado
WO2004037165A3 (en) Nitric oxide and its biomedical significance
MX2023008775A (es) 5-fluoro-4-imino-3-metil-1-tosil-3,4-dihidropirimidin-2(1h)-ona para control de enfermedades de plantas.
CN106105997A (zh) 一种核桃病虫害防治方法
DE602004011786D1 (de) Taurin bromamin für die inhibierung von pathogenen bakterien und pilzwachstum sowie in einer mikrobiziden zusammensetzung
KR20120022120A (ko) 고추 탄저병 병원균 방제를 위한 은 나노액 및 이를 이용한 고추 탄저병 병원균 방제방법
RU2472337C2 (ru) Способ биологизированной защиты винограда от болезней
BR0016426B1 (pt) mÉtodo para melhorar a produÇço de frutos das plantas.
ATE367164T1 (de) Verwendung von 4-thiouridin oder isomaltitol zur behandlung von entzündungen und/oder hämostasis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A, 7A E 8A ANUIDADE(S).

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: NAO APRESENTADA A GUIA DE CUMPRIMENTO DE EXIGENCIA. REFERENTE AS 6A, 7A E 8A ANUIDADES.